Efficacy and Safety of Mepolizumab in Adults With Chronic Rhinosinusitis With Nasal Polyps (CRSwNP)/ Eosinophilic Chronic Rhinosinusitis (ECRS) (MERIT)
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. |
ClinicalTrials.gov Identifier: NCT04607005 |
Recruitment Status :
Completed
First Posted : October 28, 2020
Last Update Posted : February 14, 2024
|
Sponsor:
GlaxoSmithKline
Collaborators:
BioClinica, Inc.
Signant Health
Information provided by (Responsible Party):
GlaxoSmithKline
- Study Details
- Tabular View
- Results Submitted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
Recruitment Status : | Completed |
---|---|
Actual Primary Completion Date : | April 12, 2023 |
Actual Study Completion Date : | April 12, 2023 |
Submission Cycle | Results Submitted to ClinicalTrials.gov | Results Returned after Quality Control Review |
---|---|---|
1 |
April 11, 2024 |